Meeting with community at EASLnews The Valdig Group Track Hub session was packed. Thank you Aurélie PLESSIER and Michael Praktiknjo for a great overview of the VALDIG activities 🎊👍

About to present EASL Education guidelines on vascular liver diseases #EASL2024 on behalf of a fantastic panel of experts‼️

Can’t wait to see it fully published EASLnews !! Valdig Group ERN RARE LIVER

Well done Silvia Affò !!! Congrats

#LiverTwitter, the wrap-up talks, summarising the best science presented at #EASLCongress, are now available for the full community through the Congress website! Watch them now: easlcongress.eu

Send your application for the AASLD-EASL Masterclass 2024 by next Monday: easl.eu/event/aasld-ea… #LiverTwitter

🟪NEW Article in press❕ Acute Liver Failure: A Practical Update 🔓#OpenAccess at 👉jhep-reports.eu/article/S2589-… #LiverTwitter #LiverDisease

Read of the weekend 👇🏼! Octavi Bassegoda LiverUnit.Clinic.BCN

Exciting experience as faculty in the my_UEG #SuSo24… HVPG, TIPS, TJLB, and much more!!! Sociedad Española de Patología Digestiva (SEPD) Edilmar Alvarado Sarah Virginia

🎉Our new Impact Factor is 9.5🎉 👏Many thanks to the Editorial Team, our peer reviewers, and very innovative authors❗️ Jessica Zucman-Rossi EASLnews EASL Education #LiverTwitter

Felicidades Sonia Fdez-Veledo !

📢🆕 Valdig Group study just out in HEPATOLOGY Journal Want to spare endoscopies in patients with PSVD❓ Spleen stiffness measurement < 40 kPa ➕ serum bilirubin < 1 mg/dL 🟰 < 5% of high risk varices ➡️ 21 to 38 % of endoscopies can be avoided journals.lww.com/hep/abstract/9…

It's out: The standard reference on 🩸portal vein thrombosis🩸 👉 diagnosis 👉 management 👉 endpoints for future clinical studies Chapeau Rautou Pierre-Emmanuel & team 🔗 authors.elsevier.com/c/1jO-d8nByrCi… #LiverTwitter The Lancet Gastroenterology & Hepatology

New Review - Elkrief et al - Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies thelancet.com/journals/langa… ERN RARE LIVER Valdig Group #LiverTwitter Rautou Pierre-Emmanuel

MASH-related cirrhosis has its own particularities. How to design clinical trials in these patients ? We defined key end-points and guide the study design. Read this consensus statement in Nature Reviews Gastroenterology & Hepatology organized by LiverUnit_VallHebron. t.ly/UZ8tY Asociación Española para el Estudio del Hígado EASL Education

📢Excited to share our paper!! 👉Esophageal varices can persist after cure even if HVPG <10mmHg 👉HVPG effectively reflects portal pressure in regression 👉Varices may not always indicate CSPH after cirrhosis cure Hospital Clínic CIBERehd Asociación Española para el Estudio del Hígado jhep-reports.eu/article/S2589-…

Join us for our 1-day CME on complex #liver disease. We look forward to seeing you there! #BigGutLiver2024 #GItwitter @northuphepTXP @AMliapakis saikiran kilaru Virginia Date: September 20, 2024 Location: NYC Register: nyulmc.org/livercme or bar code

New @ISTH guidance on anticoagulation for AF, DVT/PE and PVT in patients with cirrhosis from the SSC. Want to know who to treat, when to use a DOAC and more? Click jthjournal.org/article/S1538-… McMaster University Department of Medicine Virginia @Gendronnico Deborah Siegal Lara Roberts Alexander Gatt

"Best buy interventions to address the burden of steatotic liver disease". Out Today in the The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa… Join the discussion at the first United Nations General Assembly MASH side-event, 23 Sept 2024 in NYC: events.economist.com/custom-events/… #LiverTwitter

Had a great time!!! We enjoyed ourselves, argued, agreed and save our friendship😂😂. Thanks ALEH for this fantastic meeting!